Quarterly Disclosure

Finsbury Worldwide Pharm Tst PLC 05 January 2004 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC (the 'Company') QUARTERLY STATEMENT OF INVESTMENTS In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii), the Company discloses the following: • Investments valuing greater than 5% of the Company's gross assets comprise the following: Company Name Value of Investment at % of Total 31December 2003 Portfolio Assets Genentech Inc 13,729,947 6.13 Pfizer Inc 12,824,624 5.73 Novartis 11,722,154 5.23 Amgen Com 11,544,239 5.15 • The ten largest investments held by the Company comprise the following: Company Name Value of Investment at % of Total 31 December 2003 Portfolio Assets Genentech Inc 13,729,947 6.13 Pfizer Inc 12,824,624 5.73 Novartis 11,722,154 5.23 Amgen Com 11,544,239 5.15 Genzyme Corp General Division com 11,028,126 4.92 Lilly (Eli) * Company Com 11,000,419 4.91 Altana AG 10,875,512 4.86 Wyeth Com 10,430,076 4.66 Serono SA 'B' 10,351,852 4.62 Schering-Plough Corporation com 9,705,891 4.33 - ENDS - For further information please contact: Tracey Gower, Company Secretary Close Finsbury Asset Management Limited Telephone: 020 7426 6219 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings